Write with Gemini 4 Hydrogen — ~40% less drafting time and over 5× fewer fabricated claims.

OpenSolicitationSolicitation DRIVeEZBAA22100SOL00003

BARDA DRIVe EZ-BAA Research Opportunities

Buyer
Department of Health and Human Services
Listing location
U.S. Federal Government
Submission deadline
Oct 18, 20274:30 PM EDT

Draft your response

Create a free account to draft a response using this RFP and your company documents.

1 proposal a month on Free · No credit card required

Team preparing a proposal together
0 of 5 free RFP views today

What the buyer needs

AI summary

This announcement solicits research opportunities through the BARDA DRIVe EZ-BAA, now identified as EZ-BAA-22-100-SOL-00003. It supersedes previous versions of the BARDA DRIVe EZ-BAA. Several Areas of Interest (AOI) have been opened or revised through amendments, including ReDIRECT, Lab at Home, Digital MCMs, Host-Directed Therapeutics, Healing Lungs, DRIVe Forward, Vaccines on Demand, ReBooT, Host-Based Diagnostics, REPAIR, and FASTx. Specific closing dates for certain AOIs have been updated, paused, or reopened. For instance, AOI #15: ReDIRECT has a new closing date of February 15, 2023, and AOI #21: Vaccines on Demand has been reopened.

Incumbent and award research

No incumbent history found for this requirement. The notice does not cite a current contract, and no earlier award from this buying office matches it.

Market context

Awards in the same category (Research and Development in Biotechnology (except Nanobiotechnology)). This is not this requirement's award history.

Recent similar awards: Department of Health and Human Services, NAICS 541714

Vendor and awardValueEnds
AMGEN USA INC75A50122C00065 · TREATMENT FOR USE IN A MASS CASUALTY EVENT WHERE THROMBOCYTOPENIA OR PLATELET LOSS IS A MA$839.9MSep 29, 2032
4J THERAPEUTICS INC75A50124C00052 · THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO DEMONSTRATE THE VERSATILITY AND EFFICACY OF O$63.1MMar 31, 2032
BASILEA PHARMACEUTICA INTERNATIONAL LTD, ALLSCHWIL75A50124C00033 · THE DEVELOPMENT OF ANTIMICROBIALS FOR THE TREATMENT OF RESISTANT FUNGAL AND BACTERIAL INFE$122.5MMar 31, 2032
SRI INTERNATIONAL75N93026F00002 · TO AWARD TASK ORDER C03$722.0KFeb 19, 2032
ADVANCED TECHNOLOGY INTERNATIONAL75A50123F61002 · OT TASK ORDER 2$129.1MJan 31, 2032

Top vendors in this category: Department of Health and Human Services, NAICS 541714, since Oct 1, 2024

1,152 contract awards in this NAICS over the period.

  1. 1. ALBERT B. SABIN VACCINE INSTITUTE, INC. (THE)$336.6M
  2. 2. AMGEN USA INC$215.9M
  3. 3. START2 GROUP, INC.$194.3M
  4. 4. SHIONOGI INC$156.1M
  5. 5. MAPP BIOPHARMACEUTICAL, INC.$133.1M

Source: USAspending.gov federal award data (U.S. federal public data). A contract is called the incumbent only when the notice or its documents cite it by number.